![Maud Bouvier](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Maud Bouvier worked as a Vice President of Business Development at Sangamo Therapeutics France SAS. Prior to this, she obtained a doctorate degree from Université Joseph Fourier and a graduate degree from Grenoble Ecole de Management.
| Bedrijven | Functie | Einde |
|---|---|---|
| TXCELL | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 3 |
|---|---|
Université Joseph Fourier
 Université Joseph Fourier Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sangamo Therapeutics France SAS
 Sangamo Therapeutics France SAS BiotechnologyHealth Technology Develops cellular immunotherapy platforms that treats severe inflammatory and autoimmune diseases | Health Technology |
Grenoble Ecole de Management
 Grenoble Ecole de Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau
